Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Polli

Showing results (251-260 of 420) with videos related to

Pageof 42
Sort By:
Acta Medica Austriaca|January 1, 1985
[Interferon in the treatment of multiple myeloma]R Kuzmits, H Ludwig, A Cortelezzi, et al.
Clinical Nephrology|October 1, 1982
Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregationG Buccianti, E Pogliani, R Miradoli, et al.
Cancer|October 15, 1990
Immunophenotypes in "classical" B-cell chronic lymphocytic leukemia. Correlation with normal cellular counterpart and clinical findingsL Baldini, L Cro, A Cortelezzi, et al.
Basic and Applied Histochemistry|January 1, 1987
"In vitro" biological activity of a synthetic pentapeptide of myeloid cellsP Foa, F Chillemi, L Lombardi, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 1, 1988
BioethicsE Polli, A Bompiani, A O Carbonara, et al.
Haematologica|January 1, 1983
Methotrexate with N5-methyl-tetrahydrofolic acid in the treatment of non-Hodgkin's lymphomas and acute leukemiasM Cortellaro, C Boschetti, F Di Padova, et al.
The International Journal of Biological Markers|January 1, 1990
Immunoreactive calcitonin: a tumor marker for myelogenous leukemiasP Foa, S Ortolani, E M Pogliani, et al.
Journal of Endocrinological Investigation|June 1, 1983
Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidismM Peracchi, F Bamonti-Catena, L Lombardi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Schizophrenia Research|February 2, 2006
Schizophrenia patients show intact immediate error-related performance adjustments on an antisaccade taskFrida E Polli, Jason J S Barton, Mark Vangel, et al.
Pageof 42

Showing results (251-260 of 420) with videos related to

Sort By:
Pageof 42
Acta Medica Austriaca|January 1, 1985
[Interferon in the treatment of multiple myeloma]R Kuzmits, H Ludwig, A Cortelezzi, et al.
Clinical Nephrology|October 1, 1982
Reduction of plasma levels of betathromboglobulin and platelet factor 4 during hemodialysis: a possible role for a short acting inhibitor of platelet aggregationG Buccianti, E Pogliani, R Miradoli, et al.
Cancer|October 15, 1990
Immunophenotypes in "classical" B-cell chronic lymphocytic leukemia. Correlation with normal cellular counterpart and clinical findingsL Baldini, L Cro, A Cortelezzi, et al.
Basic and Applied Histochemistry|January 1, 1987
"In vitro" biological activity of a synthetic pentapeptide of myeloid cellsP Foa, F Chillemi, L Lombardi, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|January 1, 1988
BioethicsE Polli, A Bompiani, A O Carbonara, et al.
Haematologica|January 1, 1983
Methotrexate with N5-methyl-tetrahydrofolic acid in the treatment of non-Hodgkin's lymphomas and acute leukemiasM Cortellaro, C Boschetti, F Di Padova, et al.
The International Journal of Biological Markers|January 1, 1990
Immunoreactive calcitonin: a tumor marker for myelogenous leukemiasP Foa, S Ortolani, E M Pogliani, et al.
Journal of Endocrinological Investigation|June 1, 1983
Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidismM Peracchi, F Bamonti-Catena, L Lombardi, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Schizophrenia Research|February 2, 2006
Schizophrenia patients show intact immediate error-related performance adjustments on an antisaccade taskFrida E Polli, Jason J S Barton, Mark Vangel, et al.
Pageof 42